Top Companies by Buyback Spend in Healthcare
Largest public companies ranked by buyback spend in Healthcare on a trailing twelve months basis. Compare top issuers, sector peers and historical context on…
How TTM buyback spend is measured
Trailing twelve months (TTM) buyback spend is the dollar amount a company spent repurchasing its own common stock over the most recent four fiscal quarters, taken from the financing section of the cash flow statement and shown here as a positive amount of cash deployed. Buybacks return capital to shareholders by shrinking the share count, increasing each remaining share's claim on future earnings.
Buybacks are one of two main capital-return tools — pair this list with dividends paid for the full picture, and with stock-based compensation to see how much of repurchase activity simply offsets new equity grants. Ranked in USD after period-average FX translation (IAS 21). Rankings USD translation methodology · IFRS IAS 21 (official)
Calculated from each company's four most recent reported quarters, as of .
Sector scopeHealthcareChange sectorChange sector
Top companies by Buyback Spend — Healthcare
- Sector
- Healthcare
- Buyback Spend
- $12.03B
- As of
- Sector
- Healthcare
- Buyback Spend
- $9.13B
- As of
- Sector
- Healthcare
- Buyback Spend
- $8.00B
- As of
- Merck & Co.
MRK
- Sector
- Healthcare
- Buyback Spend
- $6.25B
- As of
- Sector
- Healthcare
- Buyback Spend
- $5.95B
- As of
- Eli Lilly
LLY
- Sector
- Healthcare
- Buyback Spend
- $4.11B
- As of
- Cigna
CI
- Sector
- Healthcare
- Buyback Spend
- $3.62B
- As of
- Sector
- Healthcare
- Buyback Spend
- $3.44B
- As of
- Sector
- Healthcare
- Buyback Spend
- $3.42B
- As of
- Zoetis
ZTS
- Sector
- Healthcare
- Buyback Spend
- $3.23B
- As of
- Sector
- Healthcare
- Buyback Spend
- $2.85B
- As of
- IQVIA
IQV
- Sector
- Healthcare
- Buyback Spend
- $2.28B
- As of
- McKesson
MCK
- Sector
- Healthcare
- Buyback Spend
- $2.14B
- As of
- Sector
- Healthcare
- Buyback Spend
- $2.02B
- As of
- Danaher
DHR
- Sector
- Healthcare
- Buyback Spend
- $2.02B
- As of
- Gilead Sciences
GILD
- Sector
- Healthcare
- Buyback Spend
- $1.92B
- As of
- Sector
- Healthcare
- Buyback Spend
- $1.90B
- As of
- DaVita
DVA
- Sector
- Healthcare
- Buyback Spend
- $1.79B
- As of
- Sector
- Healthcare
- Buyback Spend
- $1.22B
- As of
- AbbVie
ABBV
- Sector
- Healthcare
- Buyback Spend
- $980.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $967.95M
- As of
- Sector
- Healthcare
- Buyback Spend
- $893.00M
- As of
- Medtronic
MDT
- Sector
- Healthcare
- Buyback Spend
- $874.00M
- As of
- Henry Schein
HSIC
- Sector
- Healthcare
- Buyback Spend
- $850.00M
- As of
- Revvity
RVTY
- Sector
- Healthcare
- Buyback Spend
- $820.82M
- As of
- Sector
- Healthcare
- Buyback Spend
- $800.00M
- As of
- Illumina
ILMN
- Sector
- Healthcare
- Buyback Spend
- $742.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $724.00M
- As of
- Viatris
VTRS
- Sector
- Healthcare
- Buyback Spend
- $500.50M
- As of
- ResMed
RMD
- Sector
- Healthcare
- Buyback Spend
- $500.06M
- As of
- Sector
- Healthcare
- Buyback Spend
- $500.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $500.00M
- As of
- DexCom
DXCM
- Sector
- Healthcare
- Buyback Spend
- $500.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $487.00M
- As of
- Centene
CNC
- Sector
- Healthcare
- Buyback Spend
- $463.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $461.70M
- As of
- Sector
- Healthcare
- Buyback Spend
- $450.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $450.00M
- As of
- Align Technology
ALGN
- Sector
- Healthcare
- Buyback Spend
- $390.44M
- As of
- AptarGroup
ATR
- Sector
- Healthcare
- Buyback Spend
- $365.00M
- As of
- Sector
- Healthcare
- Buyback Spend
- $360.67M
- As of
- Sector
- Healthcare
- Buyback Spend
- $298.40M
- As of
- Sector
- Healthcare
- Buyback Spend
- $290.10M
- As of
- AstraZeneca
AZN
- Sector
- Healthcare
- Buyback Spend
- $211.58M
- As of
- STERIS
STE
- Sector
- Healthcare
- Buyback Spend
- $207.26M
- As of
- Bio-Techne
TECH
- Sector
- Healthcare
- Buyback Spend
- $200.15M
- As of
- Novo Nordisk
NVO
- Sector
- Healthcare
- Buyback Spend
- $195.80M
- As of
- Humana
HUM
- Sector
- Healthcare
- Buyback Spend
- $151.00M
- As of
- Stryker
SYK
- Sector
- Healthcare
- Buyback Spend
- $132.00M
- As of
- GE HealthCare
GEHC
- Sector
- Healthcare
- Buyback Spend
- $100.00M
- As of
- Insulet
PODD
- Sector
- Healthcare
- Buyback Spend
- $59.60M
- As of
- Cencora
COR
- Sector
- Healthcare
- Buyback Spend
- $50.00M
- As of
- Incyte
INCY
- Sector
- Healthcare
- Buyback Spend
- $19.10M
- As of
- Sector
- Healthcare
- Buyback Spend
- $14.67M
- As of
| # | Company | Sector | Buyback Spend | As of |
|---|---|---|---|---|
| 1 | UnitedHealth Group (UNH) | Healthcare | $12.03B | |
| 2 | HCA Healthcare (HCA) | Healthcare | $9.13B | |
| 3 | Thermo Fisher Scientific (TMO) | Healthcare | $8.00B | |
| 4 | Merck & Co. (MRK) | Healthcare | $6.25B | |
| 5 | Johnson & Johnson (JNJ) | Healthcare | $5.95B | |
| 6 | Eli Lilly (LLY) | Healthcare | $4.11B | |
| 7 | Cigna (CI) | Healthcare | $3.62B | |
| 8 | Regeneron Pharmaceuticals (REGN) | Healthcare | $3.44B | |
| 9 | Intuitive Surgical (ISRG) | Healthcare | $3.42B | |
| 10 | Zoetis (ZTS) | Healthcare | $3.23B | |
| 11 | Elevance Health (ELV) | Healthcare | $2.85B | |
| 12 | IQVIA (IQV) | Healthcare | $2.28B | |
| 13 | McKesson (MCK) | Healthcare | $2.14B | |
| 14 | Vertex Pharmaceuticals (VRTX) | Healthcare | $2.02B | |
| 15 | Danaher (DHR) | Healthcare | $2.02B | |
| 16 | Gilead Sciences (GILD) | Healthcare | $1.92B | |
| 17 | Cardinal Health (CAH) | Healthcare | $1.90B | |
| 18 | DaVita (DVA) | Healthcare | $1.79B | |
| 19 | IDEXX Laboratories (IDXX) | Healthcare | $1.22B | |
| 20 | AbbVie (ABBV) | Healthcare | $980.00M | |
| 21 | Universal Health Services (UHS) | Healthcare | $967.95M | |
| 22 | Abbott Laboratories (ABT) | Healthcare | $893.00M | |
| 23 | Medtronic (MDT) | Healthcare | $874.00M | |
| 24 | Henry Schein (HSIC) | Healthcare | $850.00M | |
| 25 | Revvity (RVTY) | Healthcare | $820.82M | |
| 26 | Mettler Toledo (MTD) | Healthcare | $800.00M | |
| 27 | Illumina (ILMN) | Healthcare | $742.00M | |
| 28 | Zimmer Biomet Holdings (ZBH) | Healthcare | $724.00M | |
| 29 | Viatris (VTRS) | Healthcare | $500.50M | |
| 30 | ResMed (RMD) | Healthcare | $500.06M | |
| 31 | Becton, Dickinson and (BDX) | Healthcare | $500.00M | |
| 32 | Molina Healthcare (MOH) | Healthcare | $500.00M | |
| 33 | DexCom (DXCM) | Healthcare | $500.00M | |
| 34 | Agilent Technologies (A) | Healthcare | $487.00M | |
| 35 | Centene (CNC) | Healthcare | $463.00M | |
| 36 | Edwards Lifesciences (EW) | Healthcare | $461.70M | |
| 37 | Quest Diagnostics (DGX) | Healthcare | $450.00M | |
| 38 | Labcorp Holdings (LH) | Healthcare | $450.00M | |
| 39 | Align Technology (ALGN) | Healthcare | $390.44M | |
| 40 | AptarGroup (ATR) | Healthcare | $365.00M | |
| 41 | Charles River (CRL) | Healthcare | $360.67M | |
| 42 | West Pharmaceutical Services (WST) | Healthcare | $298.40M | |
| 43 | Cooper Companies (COO) | Healthcare | $290.10M | |
| 44 | AstraZeneca (AZN) | Healthcare | $211.58M | |
| 45 | STERIS (STE) | Healthcare | $207.26M | |
| 46 | Bio-Techne (TECH) | Healthcare | $200.15M | |
| 47 | Novo Nordisk (NVO) | Healthcare | $195.80M | |
| 48 | Humana (HUM) | Healthcare | $151.00M | |
| 49 | Stryker (SYK) | Healthcare | $132.00M | |
| 50 | GE HealthCare (GEHC) | Healthcare | $100.00M | |
| 51 | Insulet (PODD) | Healthcare | $59.60M | |
| 52 | Cencora (COR) | Healthcare | $50.00M | |
| 53 | Incyte (INCY) | Healthcare | $19.10M | |
| 54 | Waters Corporation (WAT) | Healthcare | $14.67M |